- Home
- GPRK vs ETON Comparison
GPRK vs ETON Comparison
Compare GPRK & ETON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GPRK
- ETON
- Stock Information
- Founded
- GPRK 2002
- ETON 2017
- Country
- GPRK Colombia
- ETON United States
- Employees
- GPRK N/A
- ETON N/A
- Industry
- GPRK Oil & Gas Production
- ETON Biotechnology: Pharmaceutical Preparations
- Sector
- GPRK Energy
- ETON Health Care
- Exchange
- GPRK Nasdaq
- ETON Nasdaq
- Market Cap
- GPRK 335.7M
- ETON 388.3M
- IPO Year
- GPRK N/A
- ETON 2018
- Fundamental
- Price
- GPRK $6.66
- ETON $17.04
- Analyst Decision
- GPRK Buy
- ETON Strong Buy
- Analyst Count
- GPRK 1
- ETON 3
- Target Price
- GPRK $11.00
- ETON $29.67
- AVG Volume (30 Days)
- GPRK 589.7K
- ETON 382.9K
- Earning Date
- GPRK 08-05-2025
- ETON 08-07-2025
- Dividend Yield
- GPRK 8.83%
- ETON N/A
- EPS Growth
- GPRK N/A
- ETON N/A
- EPS
- GPRK 0.81
- ETON N/A
- Revenue
- GPRK $560,354,000.00
- ETON $58,181,000.00
- Revenue This Year
- GPRK N/A
- ETON $101.12
- Revenue Next Year
- GPRK $3.01
- ETON $45.71
- P/E Ratio
- GPRK $8.26
- ETON N/A
- Revenue Growth
- GPRK N/A
- ETON 85.40
- 52 Week Low
- GPRK $5.66
- ETON $3.87
- 52 Week High
- GPRK $11.72
- ETON $21.48
- Technical
- Relative Strength Index (RSI)
- GPRK 48.50
- ETON 64.20
- Support Level
- GPRK $6.50
- ETON $13.99
- Resistance Level
- GPRK $6.87
- ETON $17.50
- Average True Range (ATR)
- GPRK 0.24
- ETON 0.90
- MACD
- GPRK 0.02
- ETON 0.26
- Stochastic Oscillator
- GPRK 66.42
- ETON 86.70
About GPRK Geopark Ltd
GeoPark Ltd is a Latin American oil and gas exploration and production company with assets in Colombia, Ecuador, Chile, Brazil, and Argentina. The company generates revenue from the sale of crude oil, condensate, and natural gas, net of value-added tax and discounts related to the sale and overriding royalties due to the ex-owners of oil and gas properties where the royalty arrangements represent a retained working interest in the property.
About ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.